Analyst picks & changes

SciClone Pharmaceuticals Inc.

(SCLN)

Josephthal Lyon & Ross analyst Franklin Berger raised SCLN to "buy" from "hold" in anticipation of favorable data from

Read the full 234 word article

How to gain access

Continue reading with a
two-week free trial.